Patents by Inventor John H. Owoc

John H. Owoc has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11877989
    Abstract: A nutritional supplement contains 50% to 80% by weight of trimethylglycine; 5% to 30% by weight of L-?-glycerophosphorylcholine; 5% to 15% by weight of caffeine; and 5% to 10% by weight of an ingredient selected from the group consisting of an L-amino acid, creatyl-L-leucine, Corynanthe yohimbe bark extract, theacrine, and mixtures thereof. The nutritional supplement is useful for enhancing energy, mental acuity, cognitive performance, and reaction time in a subject in need thereof.
    Type: Grant
    Filed: June 14, 2021
    Date of Patent: January 23, 2024
    Assignee: Energy Beverages LLC
    Inventors: Liangxi Li, John H. Owoc
  • Publication number: 20230128454
    Abstract: A formulation for providing hydration and nutritional components to a subject includes from about 1,000 mg/serving to about 7,000 mg/serving of trimethylglycine, a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable precursor thereof; from about 1 mg/serving to about 4,000 mg/serving of beta-hydroxybutyric acid or a pharmaceutically acceptable salt thereof; an electrolyte salt; optionally a purine nucleotide; and optionally a carbohydrate. The formulation may be an orally administered liquid including an aqueous carrier in an amount sufficient to provide a total volume/serving of about 2 oz. to about 32 oz.
    Type: Application
    Filed: October 24, 2022
    Publication date: April 27, 2023
    Inventors: John H. Owoc, Liangxi Li
  • Publication number: 20230044870
    Abstract: A blow-molded bottle for a carbonated beverage includes a threaded mouth, a cylindrical side wall, a bottom, and a standard fill capacity of 37.5 mL to 105 mL. The bottle is blow-molded from a laminated preform including an outer layer formed from polyethylene terephthalate, an intermediate gas barrier layer formed from a polyamide comprising a dicarboxylic acid component and a diamine component comprising m-xylylenediamine, and an inner layer comprising polyethylene terephthalate. The laminated preform may weigh from about 4 to 16 grams. The polyamide layer provides the bottle with excellent resistance to carbon dioxide, hydrogen, and nitrogen transmission and prevents the degradation of nutrients and flavors.
    Type: Application
    Filed: July 20, 2021
    Publication date: February 9, 2023
    Inventor: John H. OWOC
  • Patent number: 11504344
    Abstract: This invention discloses a nutritional composition of matter that effectively provide a nootropic effect beyond the effects simple obtain by cannabinoids alone. Effectively reduce anxiety due to ingestion of xanthines containing oral products. Similarly reduce the side effects associated with the exogenous ingestion of yohimbine and its derivatives.
    Type: Grant
    Filed: August 15, 2019
    Date of Patent: November 22, 2022
    Assignee: JHO Intellectual Property Holdings, LLC
    Inventor: John H. Owoc
  • Publication number: 20220306975
    Abstract: A hard seltzer is made by dissolving a sodium ion source in an aqueous ethanol solution, wherein the aqueous ethanol solution comprises from 1% to 14% by volume of ethanol; dissolving a potassium ion source in the aqueous ethanol solution; dissolving a magnesium ion source in the aqueous ethanol solution; and carbonating the aqueous ethanol solution to produce the hard seltzer. The sodium ion source, the potassium ion source, and the magnesium ion source are used in amounts effective to provide a hard seltzer comprising 20 to 400 mg/serving of sodium ions, 20 to 400 mg/serving of potassium ions; and 3 to 400 mg/serving of magnesium ions.
    Type: Application
    Filed: March 29, 2022
    Publication date: September 29, 2022
    Inventors: John H Owoc, Liangxi Li
  • Publication number: 20220211640
    Abstract: Various embodiments relate to bioactive compositions, including a first component including 1 to 300 mg/dose of a psychotropic cannabinoid, a non-psychotropic cannabinoid, or a mixture thereof; a second component including 1 to 400 mg/dose of a methylxanthine; and an aqueous carrier.
    Type: Application
    Filed: March 21, 2022
    Publication date: July 7, 2022
    Inventors: John H. Owoc, Liangxi Li
  • Patent number: 11278516
    Abstract: This invention discloses a medicinal composition of matter that effectively provide a nootropic effect beyond the effects simple obtain by cannabinoids alone. And, effectively reduce anxiety due to ingestion of xanthines containing oral products.
    Type: Grant
    Filed: August 15, 2019
    Date of Patent: March 22, 2022
    Assignee: COGNITIVE IP HOLDINGS, LLC
    Inventor: John H Owoc
  • Publication number: 20210386692
    Abstract: A nutritional supplement contains 50% to 80% by weight of trimethylglycine; 5% to 30% by weight of L-?-glycerophosphorylcholine; 5% to 15% by weight of caffeine; and 5% to 10% by weight of an ingredient selected from the group consisting of an L-amino acid, creatyl-L-leucine, Corynanthe yohimbe bark extract, theacrine, and mixtures thereof. The nutritional supplement is useful for enhancing energy, mental acuity, cognitive performance, and reaction time in a subject in need thereof.
    Type: Application
    Filed: June 14, 2021
    Publication date: December 16, 2021
    Inventors: Liangxi Li, John H. Owoc
  • Publication number: 20210046039
    Abstract: This invention discloses a medicinal composition of matter that effectively provide a nootropic effect beyond the effects simple obtain by cannabinoids alone. And, effectively reduce anxiety due to ingestion of xanthines containing oral products.
    Type: Application
    Filed: August 15, 2019
    Publication date: February 18, 2021
    Inventor: John H Owoc
  • Publication number: 20210046017
    Abstract: This invention discloses a nutritional composition of matter that effectively provide a nootropic effect beyond the effects simple obtain by cannabinoids alone. Effectively reduce anxiety due to ingestion of xanthines containing oral products. Similarly reduce the side effects associated with the exogenous ingestion of yohimbine and its derivatives.
    Type: Application
    Filed: August 15, 2019
    Publication date: February 18, 2021
    Inventor: John H. Owoc
  • Publication number: 20200068939
    Abstract: This invention discloses a nutritional composition of matter that effectively reduces and stabilize glucose levels in the blood of mammals by deliberately inducing ketosis. The compositions comprise, Sodium Beta-Hydroxybutyrate, Potassium Beta-Hydroxybutyrate, Magnesium Beta-Hydroxybutyrate, Calcium Beta-Hydroxybutyrate, Ketone Esters, Medium Chain Triglycerides (MCT) with at least one or more from L-Leucine, L-Lysine, L-isoleucine, Caffeine, Yohimbine, Yohimbe, Berberine and Creatine or its derivatives (such as creatine salt, and Creatyl-L-leucine).
    Type: Application
    Filed: September 4, 2018
    Publication date: March 5, 2020
    Inventor: John H. Owoc
  • Patent number: 9642825
    Abstract: Creatine derivatives and compositions containing a bioactive form of creatine. The new chemical entity comprises an acetyl creatine, N-acyl creatines, N,N-diacyl creatines or any N-acetyl creatine species with enhanced solubility and bioavailability. Also provided by this invention are various methods for providing several beneficial effects that comprise administering compositions comprising N-acetyl creatine, N-acyl creatines, N,N-diacyl creatines or any N-acetyl creatine species to a mammalian subject, either chronically or acutely.
    Type: Grant
    Filed: February 27, 2014
    Date of Patent: May 9, 2017
    Inventor: John H Owoc
  • Publication number: 20150238453
    Abstract: Creatine derivatives and compositions containing a [one or more?] bioactive form[s] of creatine. The new chemical entity comprises an acetyl creatine, N-acyl creatines, N,N-diacyl creatines or any N-acetyl creatine species with enhanced solubility and bioavailability. Also provided by this invention are various methods for providing several beneficial effects that comprise administering compositions comprising N-acetyl creatine, N-acyl creatines, N,N-diacyl creatines or any N-acetyl creatine species to a mammalian subject, either chronically or acutely.
    Type: Application
    Filed: February 27, 2014
    Publication date: August 27, 2015
    Applicant: 4141 HOLDINGS, LLC
    Inventor: John H. Owoc
  • Patent number: 9114150
    Abstract: Compositions containing one or more bioactive forms of creatine, which are aqueous compositions in which the one or more bioactive forms of creatine do not appreciably degrade into creatinine. Also are methods for providing various beneficial effects which comprise administering aqueous compositions comprising at least one creatinol O-phosphate species to a mammalian subject, either chronically or acutely.
    Type: Grant
    Filed: January 31, 2013
    Date of Patent: August 25, 2015
    Assignee: JHO INTELLECTUAL PROPERTY HOLDINGS, LLC
    Inventor: John H. Owoc
  • Publication number: 20150132440
    Abstract: A composition of dipeptides or tripeptides or ester derivatives may be used as a nutritional supplement and to modulate expression of genes associated with healthy maintenance and regulation of muscular and neurological tissue. The compositions include dipeptides and/or tripeptides of branched chain amino acids and optionally include adjuvants, anti-aging compounds and may be provided in a dissolvable powder or liquid form.
    Type: Application
    Filed: August 13, 2014
    Publication date: May 14, 2015
    Inventor: John H Owoc
  • Publication number: 20150050260
    Abstract: The present invention provides pharmaceutical and dietary compositions in which pyrroloquinoline quinone (PQQ) and its derivatives are combined with other biologically active compounds to produce a synergistic beneficial effect beyond the effect produced by PQQ or its derivatives alone. The present invention also provides methods for providing various beneficial effects which comprise administering these compositions to a mammalian subject.
    Type: Application
    Filed: August 15, 2014
    Publication date: February 19, 2015
    Inventor: John H. Owoc
  • Patent number: 8857665
    Abstract: An internal chamber incorporated with the cap of a container, for example, a disposable beverage bottle. The internal chamber has an internal bore designed to hold a powder or liquid that can be released into the container. The chamber is inserted into a bottle or similar container when the cap is placed over the opening. A push-button on the top of the cap advances an actuator within the internal bore to push a diaphragm out of the distal end outlet port in the chamber to release the ingredient(s) within the internal chamber into the container. The diaphragm also has two or more peripheral guide rails to ensure that it remains aligned with the chamber housing during those movements. Alternative embodiments utilize a dome cover over the push-button. In use, the cap of the container can be removed, which will simultaneously remove the chamber, allowing the liquid in the container to be consumed or decanted.
    Type: Grant
    Filed: November 15, 2012
    Date of Patent: October 14, 2014
    Inventor: John H. Owoc
  • Publication number: 20130143842
    Abstract: Compositions containing one or more bioactive forms of creatine, which are aqueous compositions in which the one or more bioactive forms of creatine do not appreciably degrade into creatinine. Also are methods for providing various beneficial effects which comprise administering aqueous compositions comprising at least one creatinol O-phosphate species to a mammalian subject, either chronically or acutely.
    Type: Application
    Filed: January 31, 2013
    Publication date: June 6, 2013
    Inventor: JOHN H. OWOC
  • Patent number: 8445466
    Abstract: The present invention provides amide-protected creatine molecules and compositions, containing one or more bioactive forms of creatine in aqueous compositions, wherein bioactive forms of creatine do not appreciably degrade into creatinine. Also provided are various beneficial effects of administering aqueous compositions having at least one amide-protected creatine molecule.
    Type: Grant
    Filed: April 8, 2010
    Date of Patent: May 21, 2013
    Inventor: John H. Owoc
  • Publication number: 20130119087
    Abstract: An internal chamber incorporated with the cap of a container, for example, a disposable beverage bottle. The internal chamber has an internal bore designed to hold a powder or liquid that can be released into the container. The chamber is inserted into a bottle or similar container when the cap is placed over the opening. A push-button on the top of the cap advances an actuator within the internal bore to push a diaphragm out of the distal end outlet port in the chamber to release the ingredient(s) within the internal chamber into the container. The diaphragm also has two or more peripheral guide rails to ensure that it remains aligned with the chamber housing during those movements. Alternative embodiments utilize a dome cover over the push-button. In use, the cap of the container can be removed, which will simultaneously remove the chamber, allowing the liquid in the container to be consumed or decanted.
    Type: Application
    Filed: November 15, 2012
    Publication date: May 16, 2013
    Inventor: John H. OWOC